POLD1 and central nervous system cancer: Studying tumor families with at least one glioma case each by whole-exome sequencing, rare deleterious POLE or POLD1 germline missense variants were identified in 10 of 61 (16%) families, and were shown to co-segregate with the tumor phenotype in two families with available DNA from two tumor patients.